{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:01:52Z","timestamp":1785211312171,"version":"3.55.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405051"],"award-info":[{"award-number":["82405051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpx.2026.100503","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:31:27Z","timestamp":1770312687000},"page":"100503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Brain-targeted delivery of siRNA via non-viral delivery systems, the therapeutic strategy for Alzheimer's disease\u2014Unveiling challenges and prospects"],"prefix":"10.1016","volume":"11","author":[{"given":"Lili","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100503_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106409","article-title":"Alzheimer\u2019s disease: current concept and a new hope with siRNA-liposomal system","volume":"102","author":"Abla","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0010","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/ejn.16336","article-title":"Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer\u2019s disease","volume":"59","author":"Ahmed","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0015","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1039\/D4RA01965B","article-title":"Carboxymethylcellulose encapsulated fingolimod, siRNA@ZnO hybrid nanocomposite as a new anti-Alzheimer\u2019s material","volume":"14","author":"Aljohani","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpx.2026.100503_bb0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41587-019-0205-0","article-title":"A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system","volume":"37","author":"Alterman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0025","article-title":"A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency","volume":"3","author":"Andersen","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/apjtb.apjtb_192_24","article-title":"BACE1 inhibitors: a promising therapeutic approach for the management of Alzheimer\u2019s disease","volume":"14","author":"Arya","year":"2024","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ijpx.2026.100503_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijpx.2026.100503_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijpx.2026.100503_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0050","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1093\/nar\/gkae368","article-title":"A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system","volume":"52","author":"Belgrad","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev-pharmtox-010919-023738","article-title":"Antisense drugs make sense for neurological diseases","volume":"61","author":"Bennett","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114139","article-title":"Recent advances in nanoenzymes for Alzheimer\u2019s disease treatment","volume":"244","author":"Bi","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100503_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2009.05.047","article-title":"MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier","volume":"1282","author":"Bonoiu","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0070","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1039\/D3BM02003G","article-title":"Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood-brain barrier for Alzheimer\u2019s disease treatment","volume":"12","author":"Boyetey","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020711","article-title":"Current advances of plant-based vaccines for neurodegenerative diseases","volume":"15","author":"Bravo-V\u00e1zquez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100503_bb0080","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909999","article-title":"Endo\/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer\u2019s disease","volume":"30","author":"Cai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpx.2026.100503_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fncel.2018.00313","article-title":"Effective knockdown of gene expression in primary microglia with siRNA and magnetic nanoparticles without cell death or inflammation","volume":"12","author":"Carrillo-Jimenez","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00401-016-1652-z","article-title":"Genome-wide, high-content siRNA screening identifies the Alzheimer\u2019s genetic risk factor FERMT2 as a major modulator of APP metabolism","volume":"133","author":"Chapuis","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.msec.2017.05.101","article-title":"siRNA delivery using polyelectrolyte-gold nanoassemblies in neuronal cells for BACE1 gene silencing","volume":"80","author":"Chaudhary","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpx.2026.100503_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100937","article-title":"Amyloidosis inhibition, a new frontier of the protein corona","volume":"35","author":"Chen","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100503_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: from disease code to drug role","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100503_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146190","article-title":"An effective antioxidant to mitigate reperfusion injury by tailoring CeO2 electronic structure on layered double hydroxide nanosheets","volume":"475","author":"Chen","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijpx.2026.100503_bb0120","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/brain\/awae372","article-title":"Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer\u2019s disease and synucleinopathies","volume":"148","author":"Colloby","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ijpx.2026.100503_bb0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijpx.2026.100503_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107313","article-title":"SORL1 is a receptor for tau that promotes tau seeding","volume":"300","author":"Cooper","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2217\/nnm-2018-0326","article-title":"Controlling endosomal escape using nanoparticle composition: current progress and future perspectives","volume":"14","author":"Cupic","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0145","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301762RR","article-title":"Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer\u2019s disease models","volume":"38","author":"Davis","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpx.2026.100503_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf479","article-title":"Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy","volume":"53","author":"Davis","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800917","article-title":"pH-responsive polymer nanoparticles for drug delivery","volume":"40","author":"Deirram","year":"2019","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.ijpx.2026.100503_bb0160","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/s41467-021-22301-1","article-title":"Loss of microglial SIRP\u03b1 promotes synaptic pruning in preclinical models of neurodegeneration","volume":"12","author":"Ding","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100503_bb0165","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer's disease brain","volume":"143","author":"Drummond","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ijpx.2026.100503_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","article-title":"Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice","volume":"6","author":"Duan","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijpx.2026.100503_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117263","article-title":"Nano-scale delivery systems for siRNA delivery in cancer therapy: new era of gene therapy empowered by nanotechnology","volume":"239","author":"Ebrahimi","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0180","article-title":"Rabies virus-mimicking liposomes for targeted gene therapy in Alzheimer\u2019s disease","volume":"668","author":"Erel-Akbaba","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100503_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124962","article-title":"Rabies virus-mimicking liposomes for targeted gene therapy in Alzheimer\u2019s disease","volume":"668","author":"Erel-Akbaba","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100503_bb0190","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41380-020-00926-w","article-title":"Alzheimer\u2019s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner","volume":"26","author":"Eysert","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijpx.2026.100503_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/bfgp\/elac055","article-title":"The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review","volume":"22","author":"Fakhri","year":"2023","journal-title":"Brief. Funct. Genomics"},{"key":"10.1016\/j.ijpx.2026.100503_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae031","article-title":"Interferon regulatory factor 5 regulates the phagocytosis of microglia and alleviate Alzheimer\u2019s pathology","volume":"79","author":"Fan","year":"2024","journal-title":"J. Gerontol. A"},{"key":"10.1016\/j.ijpx.2026.100503_bb0205","doi-asserted-by":"crossref","first-page":"28901","DOI":"10.1074\/jbc.M115.678326","article-title":"The Nogo\/Nogo Receptor (NgR) signal is involved in neuroinflammation through the regulation of microglial inflammatory activation","volume":"290","author":"Fang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101756","article-title":"Nanoparticle cluster depolymerizes and removes amyloid fibrils for Alzheimer\u2019s disease treatment","volume":"48","author":"Feng","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100503_bb0215","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1093\/nar\/gkae100","article-title":"A combinatorial approach for achieving CNS-selective RNAi","volume":"52","author":"Ferguson","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0220","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/alz.13703","article-title":"Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer\u2019s disease","volume":"20","author":"Ferguson","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijpx.2026.100503_bb0225","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41594-024-01252-3","article-title":"Cryo-EM structures of amyloid-\u03b2 and tau filaments in down syndrome","volume":"31","author":"Fernandez","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70011","article-title":"FOXP1 is a transcription factor for the Alzheimer\u2019s disease risk gene SORL1","volume":"169","author":"Fu","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0235","first-page":"379","article-title":"APOE \u03b14 homozygosity - a genetic form of Alzheimer disease?","volume":"20","author":"Fyfe","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer\u2019s disease brain - special emphasis on PI3K-Akt pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0245","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","article-title":"RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain","volume":"15","author":"Gao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpx.2026.100503_bb0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.expneurol.2018.06.001","article-title":"Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury","volume":"307","author":"Gao","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0255","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1007\/s12035-023-03858-y","article-title":"Presenilin2 D439A mutation induces dysfunction of mitochondrial fusion\/fission dynamics and abnormal regulation of GTPase activity","volume":"61","author":"Gao","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0260","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jnc.13841","article-title":"Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells","volume":"139","author":"Getz","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0265","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0270","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100503_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121137","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gunassekaran","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100503_bb0280","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.apsb.2018.12.010","article-title":"Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer\u2019s disease","volume":"9","author":"Guo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100503_bb0285","series-title":"Nanotechnology in Modern Animal Biotechnology: Recent Trends and Future Perspectives","first-page":"67","article-title":"Nanomaterials-based siRNA delivery: routes of administration, hurdles and role of nanocarriers","author":"Gupta","year":"2019"},{"key":"10.1016\/j.ijpx.2026.100503_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acsami.1c15305","article-title":"siRNA mediated GSK3\u03b2 knockdown targets insulin signaling pathway and rescues Alzheimer\u2019s disease pathology: evidence from in vitro and in vivo studies","volume":"14","author":"Gupta","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100503_bb0295","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1111\/jcmm.15439","article-title":"New mechanism of nerve injury in Alzheimer\u2019s disease: \u03b2-amyloid-induced neuronal pyroptosis","volume":"24","author":"Han","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0300","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/jcp.30839","article-title":"Double-negative T cells mediate M1 polarization of microglial cells via TNF-\u03b1-NLRP3 to aggravate neuroinflammation and cognitive impairment in Alzheimer\u2019s disease mice","volume":"237","author":"Han","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.007","article-title":"A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain","volume":"228","author":"Haroon","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100503_bb0310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/15476286.2022.2066334","article-title":"Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases","volume":"19","author":"Holm","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0315","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijpx.2026.100503_bb0320","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbi.2025.04.032","article-title":"SOAT1 dysregulation in astrocytes drives Blood-Brain barrier dysfunction and neuroinflammation in Alzheimer\u2019s disease","volume":"128","author":"Huang","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ijpx.2026.100503_bb0325","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00759-z","article-title":"Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u2019s disease","volume":"19","author":"Ishii","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijpx.2026.100503_bb0330","article-title":"Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer\u2019s disease","volume":"8","author":"Iyaswamy","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100503_bb0335","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/bfgp\/elm005","article-title":"RNA interference based gene therapy for neurological disease","volume":"6","author":"Jagannath","year":"2007","journal-title":"Brief. Funct. Genomic. Proteomic."},{"key":"10.1016\/j.ijpx.2026.100503_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106413","article-title":"Unlocking therapeutic potential of siRNA-based drug delivery system for treatment of Alzheimer\u2019s disease","volume":"102","author":"Jain","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149590","article-title":"Advancing Alzheimer\u2019s disease therapy through engineered exosomal macromolecules","volume":"1855","author":"Jain","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0350","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","article-title":"Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer\u2019s disease","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100503_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70121","article-title":"IGF2BP2 regulates the progression of Alzheimer\u2019s disease through m6A-mediated NLRP3 inflammasome","volume":"13","author":"Jingrui","year":"2025","journal-title":"Immun. Inflam. Dis."},{"key":"10.1016\/j.ijpx.2026.100503_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102415","article-title":"Navigating the intersection: diabetes and Alzheimer\u2019s intertwined relationship","volume":"100","author":"Kale","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijpx.2026.100503_bb0365","first-page":"4368","article-title":"Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network","volume":"127","author":"Kanski","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100503_bb0375","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer\u2019s disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107719","article-title":"Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing","volume":"31","author":"Knupp","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijpx.2026.100503_bb0390","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100503_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1208\/s12248-024-00967-x","article-title":"Liposomal formulations of anti-alzheimer drugs and siRNA for nose-to-brain delivery: design, safety and efficacy in vitro","volume":"26","author":"Lee","year":"2024","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpx.2026.100503_bb0400","article-title":"In vivo evaluation of nose-to-brain delivery of liposomal donepezil, memantine, and BACE-1 siRNA for Alzheimer\u2019s disease therapy","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.11","article-title":"Delivery of quantum dot-siRNA nanoplexes in SK-N-SH cells for BACE1 gene silencing and intracellular imaging","volume":"1","author":"Li","year":"2012","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.ijpx.2026.100503_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109618","article-title":"Interaction between hyperphosphorylated tau and pyroptosis in forskolin and streptozotocin induced AD models","volume":"121","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpx.2026.100503_bb0415","article-title":"Engineering brain-derived neurotrophic factor mRNA delivery for the treatment of Alzheimer\u2019s disease","volume":"466","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijpx.2026.100503_bb0420","doi-asserted-by":"crossref","first-page":"53177","DOI":"10.1021\/acsami.3c08756","article-title":"Enhanced nose-to-brain delivery of combined small interfering RNAs using lesion-recognizing nanoparticles for the synergistic therapy of Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpx.2026.100503_bb0425","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","article-title":"MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy","volume":"14","author":"Li","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ijpx.2026.100503_bb0430","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40035-025-00503-7","article-title":"Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Neurodegen."},{"key":"10.1016\/j.ijpx.2026.100503_bb0435","doi-asserted-by":"crossref","first-page":"19060","DOI":"10.1039\/C5NR06282A","article-title":"Graphene quantum dots for the inhibition of \u03b2 amyloid aggregation","volume":"7","author":"Liu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijpx.2026.100503_bb0440","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","article-title":"Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions","volume":"29","author":"Liu","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijpx.2026.100503_bb0445","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41392-022-01157-x","article-title":"Clusterin transduces Alzheimer-risk signals to amyloidogenesis","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100503_bb0450","article-title":"Bio-nano toolbox for precision Alzheimer\u2019s disease gene therapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0455","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-023-02357-w","article-title":"Silencing tau to treat early Alzheimer\u2019s disease","volume":"29","author":"Ljubenkov","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0460","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3233\/ADR-230025","article-title":"Antibody-mediated clearance of brain amyloid-\u03b2: mechanisms of action, effects of natural and monoclonal Anti-A\u03b2 antibodies, and downstream effects","volume":"7","author":"Loeffler","year":"2023","journal-title":"J. Alzheimer's Dis. Rep."},{"key":"10.1016\/j.ijpx.2026.100503_bb0465","doi-asserted-by":"crossref","first-page":"1902251","DOI":"10.1002\/adma.201902251","article-title":"Constrained nanoparticles deliver siRNA and sgRNA to T cells in vivo without targeting ligands","volume":"31","author":"Lokugamage","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpx.2026.100503_bb0470","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/10717544.2020.1775724","article-title":"Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer\u2019s","volume":"27","author":"Lopez-Barbosa","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100503_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.02.003","article-title":"Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics","volume":"203","author":"Lorenzer","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100503_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.803894","article-title":"Application of CRISPR\/Cas9 in Alzheimer\u2019s disease","volume":"15","author":"Lu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0485","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.apsb.2023.10.015","article-title":"miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease","volume":"14","author":"Luo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100503_bb0490","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-024-07152-0","article-title":"The link between amyloid \u03b2 and ferroptosis pathway in Alzheimer\u2019s disease progression","volume":"15","author":"Majern\u00edkov\u00e1","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpx.2026.100503_bb0495","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnmol.2017.00069","article-title":"Whole genome expression analysis in a mouse model of tauopathy identifies MECP2 as a possible regulator of Tau pathology","volume":"10","author":"Maphis","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0500","first-page":"632","article-title":"Single-cell multiregion dissection of Alzheimer's disease","author":"Mathys","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100503_bb0505","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1021\/acsnano.2c10936","article-title":"Light-activated siRNA endosomal release (LASER) by porphyrin lipid nanoparticles","volume":"17","author":"Mo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2026.100503_bb0510","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","article-title":"The landscape of nanoparticle-based siRNA delivery and therapeutic development","volume":"32","author":"Moazzam","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpx.2026.100503_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207626","article-title":"Microfluidic synthesis of ultrasmall chitosan\/graphene quantum dots particles for intranasal delivery in Alzheimer\u2019s disease treatment","volume":"19","author":"Mohebichamkhorami","year":"2023","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0520","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4103\/1673-5374.301013","article-title":"Clusterin: a multifaceted protein in the brain","volume":"16","author":"Moon","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0525","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3233\/JAD-210483","article-title":"Blood CDKN2A gene expression in aging and neurodegenerative diseases","volume":"82","author":"Mori","year":"2021","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ijpx.2026.100503_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081899","article-title":"Dendrimers-novel therapeutic approaches for Alzheimer's disease","volume":"12","author":"Mroziak","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijpx.2026.100503_bb0535","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0540","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","article-title":"Circadian rhythms in neurodegenerative disorders","volume":"18","author":"Nassan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0545","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.semcancer.2022.06.011","article-title":"Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders","volume":"86","author":"Neganova","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0550","first-page":"24","article-title":"Pegylated gold nanoparticles conjugated with siRNA: complexes formation and cytotoxicity","author":"Ok\u0142a","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0555","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1007\/s12035-023-03801-1","article-title":"Clusterin is a potential therapeutic target in Alzheimer\u2019s disease","volume":"61","author":"Palihati","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0560","doi-asserted-by":"crossref","first-page":"1184435","DOI":"10.3389\/fnagi.2023.1184435","article-title":"Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders","volume":"15","author":"Pan","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0565","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biomaterials.2014.10.068","article-title":"Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease","volume":"38","author":"Park","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100503_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer\u2019s diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0575","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ijpx.2026.100503_bb0580","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1038\/s41467-024-54777-y","article-title":"Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer\u2019s disease-relevant brain circuits","volume":"15","author":"Perdok","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100503_bb0585","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","article-title":"Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and tau tangle pathologies","volume":"27","author":"Pichet Binette","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0590","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/s41380-024-02565-x","article-title":"Thy1-ApoE4\/C\/EBP\u03b2 double transgenic mice act as a sporadic model with Alzheimer\u2019s disease","volume":"29","author":"Qian","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijpx.2026.100503_bb0595","article-title":"Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery","volume":"6","author":"Qiu","year":"2023","journal-title":"Research (Washington, D.C.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation","volume":"36","author":"Ralvenius","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0605","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","article-title":"Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy","volume":"152","author":"Rassu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100503_bb0610","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/s41591-024-03122-3","article-title":"Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer\u2019s disease","volume":"30","author":"Rosenzweig","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0615","first-page":"13","article-title":"Overcoming barriers for siRNA therapeutics: from bench to bedside","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals (Basel, Switz.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0620","first-page":"636","article-title":"Access to the CNS: strategies to overcome the BBB","author":"S\u00e1nchez-Dengra","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100503_bb0625","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijbiomac.2014.08.052","article-title":"Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery","volume":"72","author":"Sarvaiya","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0630","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.001","article-title":"Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo","volume":"295","author":"Sato","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100503_bb0635","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1021\/acs.nanolett.0c00752","article-title":"A nanoprimer to improve the systemic delivery of siRNA and mRNA","volume":"20","author":"Saunders","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpx.2026.100503_bb0640","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2024.03.042","article-title":"Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro","volume":"369","author":"Shamshiripour","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100503_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102379","article-title":"Revolutionizing Alzheimer\u2019s treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements","volume":"99","author":"Shastri","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijpx.2026.100503_bb0650","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-024-00715-x","article-title":"Rejuvenating aged microglia by p16(ink4a)-siRNA-loaded nanoparticles increases amyloid-\u03b2 clearance in animal models of Alzheimer's disease","volume":"19","author":"Shin","year":"2024","journal-title":"Mol. Neurodegen."},{"key":"10.1016\/j.ijpx.2026.100503_bb0655","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102821","article-title":"Rodent models of Alzheimer\u2019s disease: critical analysis of current hypotheses and pathways for future research","volume":"252","author":"Singhaarachchi","year":"2025","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122666","article-title":"Mesoporous silica nanoparticles: types, synthesis, role in the treatment of Alzheimer\u2019s disease, and other applications","volume":"15","author":"Sivamaruthi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100503_bb0670","doi-asserted-by":"crossref","first-page":"30670","DOI":"10.1074\/jbc.M115.691493","article-title":"The voltage-dependent anion channel 1 mediates amyloid \u03b2 toxicity and represents a potential target for Alzheimer disease therapy","volume":"290","author":"Smilansky","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0675","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13024-024-00769-x","article-title":"Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies","volume":"19","author":"Song","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijpx.2026.100503_bb0680","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jconrel.2024.12.060","article-title":"Modulation of \u03b2 secretase and neuroinflammation by biomimetic nanodelivery system for Alzheimer's disease therapy","volume":"378","author":"Song","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100503_bb0685","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2019.03.001","article-title":"Systemic peptide mediated delivery of an siRNA targeting \u03b1-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease","volume":"127","author":"Spencer","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijpx.2026.100503_bb0690","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.cell.2019.07.043","article-title":"Loss of Ataxin-1 potentiates Alzheimer's pathogenesis by elevating cerebral BACE1 transcription","volume":"178","author":"Suh","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2026.100503_bb0695","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-023-01707-w","article-title":"Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-\u03baB pathway in a chronic migraine model","volume":"25","author":"Sun","year":"2024","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ijpx.2026.100503_bb0700","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.2147\/IJN.S506793","article-title":"Intranasal delivery of BACE1 siRNA and berberine via engineered stem cell exosomes for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Sun","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100503_bb0705","first-page":"24","article-title":"Current aspects of siRNA bioconjugate for in vitro and in vivo delivery","author":"Tai","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0710","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","article-title":"Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease","volume":"19","author":"Tan","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0715","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100503_bb0720","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial","volume":"79","author":"Teng","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102203","article-title":"Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and network meta-analysis","volume":"94","author":"Terao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijpx.2026.100503_bb0730","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2012.01.015","article-title":"\u03b2-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau","volume":"9","author":"Tsolakidou","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijpx.2026.100503_bb0735","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature23479","article-title":"Channel opening and gating mechanism in AMPA-subtype glutamate receptors","volume":"549","author":"Twomey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100503_bb0740","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of patisiran (ONPATTRO(R)) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ijpx.2026.100503_bb0745","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0750","first-page":"125","article-title":"Synergic treatment of Alzheimer\u2019s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor","volume":"1","author":"Wang","year":"2020","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0755","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13515","article-title":"Nogo receptor impairs the clearance of fibril amyloid-\u03b2 by microglia and accelerates Alzheimer\u2019s-like disease progression","volume":"20","author":"Wang","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.ijpx.2026.100503_bb0760","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijpx.2026.100503_bb0765","article-title":"Silencing NRBP1 gene with shRNA improves cognitive function and pathological features in AD rat model","volume":"63","author":"Wei","year":"2025","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ijpx.2026.100503_bb0770","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41593-024-01610-w","article-title":"TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models","volume":"27","author":"Wilson","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijpx.2026.100503_bb0775","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1007\/s13346-023-01306-x","article-title":"Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress","volume":"13","author":"Xiang","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100503_bb0780","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","article-title":"Activation of innate immune cGAS-STING pathway contributes to Alzheimer's pathogenesis in 5\u00d7FAD mice","volume":"3","author":"Xie","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ijpx.2026.100503_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101388","article-title":"Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer\u2019s disease","volume":"43","author":"Xu","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100503_bb0790","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFalpha siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpx.2026.100503_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer\u2019s disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0800","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains","volume":"375","author":"Yang","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0805","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","article-title":"Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells","volume":"16","author":"Young","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpx.2026.100503_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120160","article-title":"MOF-encapsulated nanozyme enhanced siRNA combo: control neural stem cell differentiation and ameliorate cognitive impairments in Alzheimer's disease model","volume":"255","author":"Yu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2026.100503_bb0815","doi-asserted-by":"crossref","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","article-title":"Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia","volume":"287","author":"Yuyama","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0820","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","article-title":"RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals","volume":"101","author":"Zamore","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2026.100503_bb0825","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1074\/jbc.M109.079079","article-title":"Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100503_bb0830","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1002\/adma.201600554","article-title":"Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer\u2019s disease therapy","volume":"28","author":"Zhang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijpx.2026.100503_bb0835","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2174\/1389201019666180226152542","article-title":"A dual targeting drug delivery system for penetrating blood-brain barrier and selectively delivering siRNA to neurons for Alzheimer\u2019s disease treatment","volume":"18","author":"Zhang","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0840","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389201020666190204141046","article-title":"In vivo evaluation and Alzheimer\u2019s disease treatment outcome of siRNA loaded dual targeting drug delivery system","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100503_bb0845","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1039\/C9TB00170K","article-title":"Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges","volume":"7","author":"Zhang","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijpx.2026.100503_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101788","article-title":"Amyloid-\u03b2\/tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer\u2019s disease mice","volume":"49","author":"Zhang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.ijpx.2026.100503_bb0855","article-title":"Nano-brake halts mitochondrial dysfunction cascade to alleviate neuropathology and rescue Alzheimer\u2019s cognitive deficits","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.ijpx.2026.100503_bb0860","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.actbio.2016.11.029","article-title":"A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer\u2019s disease mice","volume":"49","author":"Zheng","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100503_bb0865","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11011-024-01472-y","article-title":"Research progress on the association of insulin resistance with type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"40","author":"Zheng","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ijpx.2026.100503_bb0870","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijpx.2026.100503_bb0875","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-023-00611-w","article-title":"BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of \u03b2-amyloid peptides","volume":"18","author":"Zhou","year":"2023","journal-title":"Mol. Neurodegen."},{"key":"10.1016\/j.ijpx.2026.100503_bb0880","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/acel.12642","article-title":"HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"Zhu","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.ijpx.2026.100503_bb0885","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-018-0295-z","article-title":"GSK3\u03b2-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions","volume":"13","author":"Zhu","year":"2018","journal-title":"Mol. Neurodegen."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259015672600023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:47:13Z","timestamp":1785210433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259015672600023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":177,"alternative-id":["S259015672600023X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100503","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-targeted delivery of siRNA via non-viral delivery systems, the therapeutic strategy for Alzheimer's disease\u2014Unveiling challenges and prospects","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100503"}}